drugset / Trial / NCT07518186
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate how well JNJ-79635322 works when compared with teclistamab.
Timeline
- Start
- 2026-05-31
- Primary completion
- 2029-04-29
- Completion
- 2032-12-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JNJ-79635322 | Unknown | — | Subcutaneous |
| Comparator | Teclistamab | Monoclonal antibody | — | Subcutaneous |